Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹9842 Cr.
Stock P/E
36
P/B
4.7
Current Price
₹227.9
Book Value
₹ 48.6
Face Value
2
52W High
₹305.3
52W Low
₹ 138.2
Dividend Yield
0%

Park Medi World Overview

Business

Park Medi World Ltd. (PARKHOSPS) operates within the Hospital & Healthcare Services sector in India. The company's core business involves establishing, owning, and managing hospitals and healthcare facilities. It provides a range of medical services including inpatient care, outpatient consultations, diagnostic services, surgical procedures, and emergency services across various medical specialties. The business model is centered on delivering comprehensive patient care. Revenue is primarily generated through patient fees for medical treatments, consultations, surgeries, room charges, diagnostic tests, and pharmacy sales.

Revenue Mix

While specific financial data for Park Medi World Ltd. is not provided, typical revenue segments for a multi-specialty hospital in India include:

Inpatient Services: Revenue from hospitalized patients, including room charges, surgical fees, medical procedures, and intensive care. This is usually the largest revenue contributor.

Outpatient Services: Revenue from consultations, minor procedures, and daycare services.

Diagnostics: Revenue from pathology, radiology, and other diagnostic tests.

Pharmacy: Revenue from sales of medicines and medical consumables.

Without specific company financials, the exact revenue mix cannot be determined, but inpatient services and associated surgeries are generally the primary drivers.

Industry

The Indian hospital and healthcare services industry is large, growing, and increasingly fragmented, consisting of large corporate hospital chains, regional multi-specialty hospitals, single-specialty hospitals, and a vast network of smaller clinics and government facilities. The industry is driven by factors such as a large population base, rising disposable incomes, increasing health awareness, and growing penetration of health insurance.

Park Medi World Ltd. likely operates as a regional or mid-sized player within this landscape. Its positioning would depend on its geographical footprint, number of beds, specialization offerings, quality of care, doctor reputation, and pricing strategy relative to larger national chains and smaller local hospitals. It competes on the basis of medical expertise, patient outcomes, infrastructure, and service quality.

MOAT

Durable competitive advantages in the hospital sector can be challenging to build. Potential sources of competitive advantage for Park Medi World Ltd. could include:

Regional Brand & Reputation: A strong brand built on trust, quality of care, and positive patient outcomes within its specific operating regions.

Doctor Talent: Ability to attract and retain highly skilled and reputed doctors, which is crucial for patient pull.

Specialized Services: Expertise in specific high-demand medical specialties that are not widely available or are of superior quality.

NABH/JCI Accreditation: Demonstrating high standards of patient care and safety, which can build trust and attract patients.

Location: Strategic placement of facilities in high-density areas with easy accessibility.

However, the sector generally faces high capital expenditure and intense competition, which can make sustained moats difficult without significant scale or unique specialization.

Growth Drivers

Key factors that can drive growth for Park Medi World Ltd. over the next 3-5 years include:

Demographic Trends: India's growing and aging population, coupled with increasing prevalence of chronic and lifestyle diseases, will drive demand for healthcare services.

Rising Healthcare Expenditure: Increasing disposable incomes and greater health awareness are leading to higher out-of-pocket and insurance-backed spending on healthcare.

Health Insurance Penetration: Expanding coverage of government and private health insurance schemes makes quality healthcare more accessible to a broader population.

Medical Tourism: Potential to attract patients from other countries or regions for specialized and cost-effective medical treatments.

Capacity Expansion & Specialty Addition: Strategic expansion of bed capacity, addition of new hospitals, and enhancement of high-demand specialties (e.g., oncology, cardiology, orthopedics).

Risks

Intense Competition: Fierce competition from established national hospital chains, other regional players, and entry of new facilities can impact patient volumes and pricing power.

Regulatory & Pricing Pressures: Government interventions, price caps on drugs, medical devices, or certain procedures can impact revenue and profitability. Changes in insurance reimbursement policies also pose a risk.

Talent Acquisition & Retention: Shortage of qualified doctors, nurses, and paramedical staff, coupled with high attrition rates, can lead to increased salary costs and operational challenges.

High Capital Expenditure: The hospital business is capital-intensive, requiring continuous investment in infrastructure, technology, and medical equipment, which can strain finances.

Reputational Risks: Medical errors, ethical issues, or negative publicity can severely damage patient trust and brand reputation.

Operational Efficiency: Managing complex operations, supply chain, and ensuring optimal bed occupancy are crucial; inefficiencies can lead to higher operating costs.

Management & Ownership

Typically, companies like Park Medi World Ltd. are founded and often controlled by promoters, who may have a strong background in healthcare or business. The quality of management is critical in the healthcare sector, impacting operational efficiency, ethical practices, patient safety, and strategic direction. A capable management team with deep industry knowledge is essential for navigating regulatory complexities, talent challenges, and competitive pressures. The ownership structure likely involves a significant stake held by the promoter group, with the remaining shares held by the public and institutional investors.

Outlook

The outlook for the Indian hospital and healthcare services sector remains largely positive, driven by strong underlying demand fundamentals. For Park Medi World Ltd., the ability to capitalize on these tailwinds will depend heavily on its strategic execution.

The bull case envisions the company effectively expanding its footprint, attracting top medical talent, maintaining high standards of patient care and safety, and building a strong regional brand, leading to sustainable growth in patient volumes and revenue. Leveraging growing health insurance penetration and potentially venturing into high-demand super-specialties could further enhance its market position.

The bear case highlights risks such as failure to effectively compete with larger players, inability to manage regulatory changes and pricing pressures, challenges in attracting and retaining skilled medical professionals, or inefficient capital allocation for expansion. Any significant lapse in patient safety or ethical standards could also severely impact its prospects.

In summary, Park Medi World Ltd. operates in a dynamic and growing industry. Its future performance will be a function of its operational excellence, strategic growth initiatives, and adept management of inherent industry-specific risks.

Park Medi World Share Price

Live · BSE / NSE · Inception: 2011
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Park Medi World Quarterly Results

#(Fig in Cr.) Dec 2024 Mar 2025 Jun 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 348 354 399 410 460 476
Other Income 15 9 7 9 8 8
Total Income 363 362 406 419 468 483
Total Expenditure 265 265 294 311 333 350
Operating Profit 98 97 112 109 135 134
Interest 16 16 15 15 14 10
Depreciation 15 16 15 15 18 19
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 67 66 82 78 103 105
Provision for Tax 21 13 16 25 27 16
Profit After Tax 46 52 66 53 77 89
Adjustments -0 -8 -8 -2 -6 -6
Profit After Adjustments 46 45 58 51 71 83
Adjusted Earnings Per Share 0.5 1.2 1.5 1.2 1.6 1.9

Park Medi World Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 1084 1255 1231 1394 1679 1745
Other Income 10 18 32 32 32 32
Total Income 1094 1272 1263 1426 1711 1776
Total Expenditure 740 864 919 1022 1233 1288
Operating Profit 354 408 344 404 478 490
Interest 40 51 72 62 61 54
Depreciation 35 41 51 57 62 67
Exceptional Income / Expenses 0 -2 -3 0 0 0
Profit Before Tax 278 315 218 286 355 368
Provision for Tax 79 87 66 70 81 84
Profit After Tax 199 228 152 215 274 285
Adjustments -19 -9 1 -14 -15 -22
Profit After Adjustments 181 220 153 202 258 263
Adjusted Earnings Per Share 4.7 5.7 4 5.2 6 6.2

Park Medi World Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 457 687 883 1052 2022
Minority's Interest 87 43 53 67 82
Borrowings 372 319 391 384 19
Other Non-Current Liabilities 24 23 53 55 134
Total Current Liabilities 353 521 527 557 529
Total Liabilities 1293 1593 1906 2115 2786
Fixed Assets 458 536 837 890 1309
Other Non-Current Assets 111 196 126 191 389
Total Current Assets 724 862 943 1034 1088
Total Assets 1293 1593 1906 2115 2786

Park Medi World Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 81 151 100 77 103
Cash Flow from Operating Activities 155 199 361 215 329
Cash Flow from Investing Activities -248 -234 -255 -100 -333
Cash Flow from Financing Activities 163 1 -130 -89 121
Net Cash Inflow / Outflow 70 -34 -23 26 116
Closing Cash & Cash Equivalent 151 117 77 103 237

Park Medi World Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 4.7 5.71 3.99 5.25 5.98
CEPS(Rs) 6.1 6.99 5.27 7.08 7.78
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 11.57 17.55 22.65 27.06 46.54
Core EBITDA Margin(%) 31.75 31.16 25.33 26.69 26.58
EBIT Margin(%) 29.4 29.19 23.56 24.94 24.74
Pre Tax Margin(%) 25.67 25.11 17.72 20.5 21.11
PAT Margin (%) 18.39 18.19 12.35 15.46 16.29
Cash Profit Margin (%) 21.62 21.42 16.46 19.54 20.01
ROA(%) 15.42 15.81 8.69 10.72 11.16
ROE(%) 44.82 40.77 19.67 22.55 17.94
ROCE(%) 33.62 33.59 21.2 21.95 21.3
Receivable days 151.16 149.17 161.19 147.26 131.17
Inventory Days 2.02 1.12 0.58 0.62 0.59
Payable days 101.2 95.04 110.67 146.53 151.21
PER(x) 0 0 0 0 31.74
Price/Book(x) 0 0 0 0 4.08
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.36 0.34 0.26 0.24 4.76
EV/Core EBITDA(x) 1.1 1.06 0.93 0.84 16.71
Net Sales Growth(%) 0 15.7 -1.88 13.2 20.51
EBIT Growth(%) 0 14.85 -20.81 19.84 19.55
PAT Growth(%) 0 14.45 -33.38 41.73 26.98
EPS Growth(%) 0 21.52 -30.13 31.37 13.93
Debt/Equity(x) 1.13 0.83 0.73 0.6 0.11
Current Ratio(x) 2.05 1.65 1.79 1.86 2.06
Quick Ratio(x) 2.03 1.65 1.79 1.85 2.05
Interest Cover(x) 7.88 7.16 4.04 5.62 6.83
Total Debt/Mcap(x) 0 0 0 0 0.03

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +20% +10% — —
Operating Profit CAGR +18% +5% — —
PAT CAGR +27% +6% — —
Share Price CAGR — — — —
ROE Average +18% +20% +29% +29%
ROCE Average +21% +21% +26% +26%

Park Medi World Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 82.89 %
FII 0.82 %
DII (MF + Insurance) 8.72 %
Public (retail) 7.56 %
Others 0.01 %
# Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 082.8982.8982.89
FII 01.280.860.82
DII 08.789.258.72
Public 07.056.997.56
Others 0000
Total 100100100100

Park Medi World Peer Comparison

Hospital & Healthcare Services Edit Columns

Park Medi World Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Park Medi World Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 20%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

    0
  • Debtor days have increased from 146.53 to 151.21days.
  • Stock is trading at 4.7 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp